Holen Sie sich die Stockscreener-App
23.40
0.86%
0.20
Schlusskurs vom Vortag:
$23.20
Offen:
$23.2
24-Stunden-Volumen:
472.65K
Relative Volume:
0.99
Marktkapitalisierung:
$655.13M
Einnahmen:
$17.16M
Nettoeinkommen (Verlust:
$-163.62M
KGV:
-3.8487
EPS:
-6.08
Netto-Cashflow:
$-121.61M
1W Leistung:
+6.85%
1M Leistung:
+16.36%
6M Leistung:
+32.13%
1J Leistung:
-38.90%
1-Tages-Spanne:
$22.87
$23.58
1-Wochen-Bereich:
$21.56
$23.64
52-Wochen-Spanne:
$12.21
$40.70
Anaptysbio Inc Stock (ANAB) Company Profile
Firmenname
Anaptysbio Inc
Sektor
Branche
Telefon
858-362-6295
Adresse
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Vergleichen Sie ANAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANAB
Anaptysbio Inc
|
23.40 | 637.22M | 17.16M | -163.62M | -121.61M | -6.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-04-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-03-12 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | BTIG Research | Buy |
| 2024-02-21 | Eingeleitet | Stifel | Buy |
| 2024-02-16 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-05-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-13 | Herabstufung | Truist | Buy → Hold |
| 2022-09-01 | Eingeleitet | Raymond James | Outperform |
| 2022-03-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-21 | Eingeleitet | UBS | Neutral |
| 2021-03-16 | Hochstufung | Truist | Hold → Buy |
| 2021-03-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-08 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2021-02-11 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2020-10-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-10-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-11-08 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2019-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-08 | Herabstufung | SunTrust | Buy → Hold |
| 2019-11-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-06-21 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | Herabstufung | Stifel | Buy → Hold |
| 2018-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-11-21 | Eingeleitet | JP Morgan | Overweight |
| 2018-07-19 | Eingeleitet | Credit Suisse | Outperform |
| 2018-04-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | Bestätigt | Stifel | Buy |
| 2018-03-06 | Bestätigt | Stifel | Buy |
| 2018-02-15 | Bestätigt | SunTrust | Buy |
| 2018-01-23 | Bestätigt | Credit Suisse | Outperform |
| 2017-11-15 | Eingeleitet | SunTrust | Buy |
| 2017-11-09 | Eingeleitet | Jefferies | Buy |
| 2017-10-11 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten
AnaptysBio, Inc. $ANAB Shares Acquired by Granahan Investment Management LLC - MarketBeat
Exome Asset Management LLC Acquires New Position in AnaptysBio, Inc. $ANAB - MarketBeat
PDT Partners LLC Makes New $828,000 Investment in AnaptysBio, Inc. $ANAB - MarketBeat
Trexquant Investment LP Grows Stake in AnaptysBio, Inc. $ANAB - MarketBeat
Does AnaptysBio Inc. have pricing powerJuly 2025 News Drivers & Low Risk Entry Point Guides - Lancaster City Council
AnaptysBio (NASDAQ:ANAB) Stock Price Up 5.1%What's Next? - MarketBeat
Rafferty Asset Management LLC Trims Holdings in AnaptysBio, Inc. $ANAB - MarketBeat
AnaptysBio Inc. Breakout Confirmed by Volume MetricsJuly 2025 Pullbacks & Weekly High Return Forecasts - beatles.ru
AnaptysBio, Inc. $ANAB Position Increased by Palo Alto Investors LP - MarketBeat
683 Capital Management LLC Takes $3.64 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat
First Light Asset Management LLC Has $86.14 Million Stock Holdings in AnaptysBio, Inc. $ANAB - MarketBeat
Nuveen LLC Invests $1.04 Million in AnaptysBio, Inc. $ANAB - MarketBeat
Earnings Recap: Will AnaptysBio Inc. outperform tech stocksJuly 2025 Price Swings & Daily Momentum Trading Reports - خودرو بانک
Will AnaptysBio Inc. benefit from geopolitical trendsJuly 2025 Retail & Weekly Return Optimization Alerts - خودرو بانک
What recovery options are there for AnaptysBio Inc.2025 Year in Review & Stock Portfolio Risk Control - Newser
Technical signs of recovery in AnaptysBio Inc.2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Will AnaptysBio Inc. outperform its industry peersJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - خودرو بانک
How sensitive is AnaptysBio Inc. to inflationBond Market & Weekly High Return Forecasts - خودرو بانک
Will AnaptysBio Inc. benefit from rising consumer demand2025 EndofYear Setup & Expert Verified Stock Movement Alerts - خودرو بانک
Trend analysis for AnaptysBio Inc. this weekJuly 2025 Volume & Low Drawdown Investment Ideas - Newser
Will AnaptysBio Inc. continue its uptrendJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - Newser
using ichimoku cloud for anaptysbio inc. technicalsWeekly Investment Report & Verified Stock Trade Ideas - Newser
Visualizing AnaptysBio Inc. stock with heatmaps2025 Fundamental Recap & AI Driven Stock Reports - Newser
AnaptysBio Inc. Outperforms Peers on Volume MetricsJuly 2025 Chart Watch & Verified Short-Term Plans - beatles.ru
AnaptysBio, Inc. $ANAB Position Trimmed by Charles Schwab Investment Management Inc. - MarketBeat
What machine learning models say about AnaptysBio Inc.2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
How to recover losses in AnaptysBio Inc. stock2025 Winners & Losers & Verified Technical Signals - Newser
Is AnaptysBio Inc. trading at a discount2025 Trading Volume Trends & Trade Opportunity Analysis Reports - خودرو بانک
Can swing trading help recover from AnaptysBio Inc. lossesJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Using Ichimoku Cloud for AnaptysBio Inc. technicalsMarket Trend Report & Free Real-Time Volume Trigger Notifications - Newser
Will AnaptysBio Inc. price bounce be sustainableJuly 2025 Levels & Real-Time Stock Movement Alerts - Newser
AnaptysBio Inc.’s volatility index tracking explainedDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Can trapped investors hope for a rebound in AnaptysBio Inc.2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Can momentum traders help lift AnaptysBio Inc.July 2025 Opening Moves & Stock Market Timing Techniques - Newser
Can AnaptysBio Inc. ride the EV waveMarket Sentiment Review & Real-Time Volume Spike Alerts - خودرو بانک
Chart based analysis of AnaptysBio Inc. trends2025 Bull vs Bear & Verified Entry Point Signals - Newser
Is AnaptysBio Inc. a cyclical or defensive stockJuly 2025 Technicals & Fast Entry and Exit Trade Plans - خودرو بانک
Historical volatility pattern of AnaptysBio Inc. visualizedJuly 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
What does recent volatility data suggest for AnaptysBio Inc.Wall Street Watch & Intraday High Probability Alerts - Newser
Finanzdaten der Anaptysbio Inc-Aktie (ANAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anaptysbio Inc-Aktie (ANAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RENTON HOLLINGS | Director |
Aug 08 '25 |
Sale |
19.62 |
10,231 |
200,714 |
4,965 |
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):